We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

02 Jun 2026 - 04 Jun 2026
17 Jun 2026 - 19 Jun 2026

Presurgical Diabetics Imperiled When Glucose Is Normal

By LabMedica International staff writers
Posted on 03 Nov 2010
Diabetic patients who presented for noncardiac surgery with near normal blood sugar levels were at increased risk of death, as compared with their nondiabetic counterparts.

There appears to be the relationship between blood sugar levels before surgery and the occurrence of complications and death after noncardiac surgeries, comparing the relationship between those with diabetes and those without.

In a study carried out at the Cleveland Clinic (Cleveland, OH, USA), specific data from surgeries on 61,536 patients who had elective surgery between January 2005 and November 2009, were analyzed. More...
The overall findings were that 15.8% had diabetes. The study examined two main outcomes: in-hospital complications after surgery (including cardiac, neurological, urologic, and infectious complications) and death within one year of surgery. The study analyzed such associations using both crude and adjusted figures. The adjusted figures took into account other factors that may have contributed to poor outcomes, such as age and heart disease.

The study found that the relationship between blood sugar levels and the likelihood of complications after surgery was not significantly different between diabetics and nondiabetics. However, the investigation showed a significant difference between diabetics and nondiabetics in terms of the relationship between blood sugar levels before surgery and deaths within one year of surgery. Nondiabetic patients with high blood sugar levels had a higher risk of dying from noncardiac surgery compared with diabetics with high blood sugar levels. Conversely, normal blood sugar levels in diabetics were associated with a higher risk of death within one year after noncardiac surgery versus nondiabetics.

Basem Abdelmalak, M.D., the study investigator, said, " Diabetics who have lived with high blood sugar for long periods of time have become accustomed to this state and may have reset their metabolism, becoming unable to tolerate lower blood glucose levels. This is similar to what happens to patients with long-term high blood pressure." The clinical study was presented at the annual meeting of the American Society of Anesthesiologist, held October 16-20, 2010, in San Diego, CA, USA.

Related Links:

Cleveland Clinic




Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
All-in-One Molecular System
AIO M160
Chromogenic Culture System
InTray™ COLOREX™ ECC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The updated CRC screening guidance adds a stool RNA test and an updated stool DNA test to the menu of preferred options (image credit: Adobe Stock)

Updated Guidance Prioritizes Stool-Based Colorectal Cancer Screening Tests

Colorectal cancer is the second-leading cause of cancer death in the United States and claimed an estimated 55,000 lives in 2026. Incidence is rising among adults younger than 50, even as overall mortality... Read more

Immunology

view channel
Image: Study design for analysis of monocyte phenotype, function, and metabolism (Gráinne Jameson et al., Journal of Infection (2026). DOI: 10.1016/j.jinf.2026.106755)

Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response

Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.